Sponsor:
Immune Oncology Research Institute
Code:
NCT05711992
Conditions
Embryonal Tumor
Eligibility Criteria
Sex: All
Age: 0 - 25
Healthy Volunteers: Not accepted
Brief summary:
Conditions
Embryonal Tumor
Study ID
NCT05711992
Start date
Feb 1, 2023
Status verified date
May, 2025
Completion date
Feb, 2033
Anticipated
Primary completion date
Feb, 2033
Anticipated
Eligibility Criteria
Sex: All
Age: 0 - 25
Healthy Volunteers: Not accepted
Enrollment
300 participants
Anticipated
Primary outcome measure
Central contacts
Locations
Children's Hospital of Eastern Ontario (CHEO)
Recruiting
Ottawa, Canada, K1H 8L1
Contacts
Consolato M Sergi, MD, PhD, MPH
csergi@cheo.on.caSponsor
Immune Oncology Research Institute
Last update posted
May 8, 2025
Last verified
May, 2025
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Immune Oncology Research Institute on 2025-05-08.